# Ypsomed completes sale of pen needle and BGM businesses to MTD

Ypsomed completed the sale of its pen needle and blood glucose monitoring businesses to Medical Technology and Devices (MTD). The deal was first announced in March 2024, and Ypsomed will transition production equipment to MTD by mid-2025.

- Type: Acquisition
- Announced: 2024-08-02
- Status: completed
- Products: pen needles, blood glucose monitoring devices
- Sectors: [Medical Devices](https://endata.com/sectors/medical-devices.md)

## Companies

- [Ypsomed](https://endata.com/companies/9625.md) (target)
- [Medical Technology and Devices Group](https://endata.com/companies/67437.md) (acquirer)

## Sources

- [drugdeliverybusiness.com](https://www.drugdeliverybusiness.com/ypsomed-completes-pen-needle-bgm-sale/), 2024-08-02: "Ypsomed announced today that it completed the sale of its pen needle and blood glucose monitoring (BGM) businesses to Medical Technology and Devices (MTD)."

---
Data from Endata (https://endata.com/). Announcements are summarized from public sources and may be incomplete; check the linked originals.